Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
L. Shalamova, U. Felgenhauer, A. R. Schaubmar, K. Buettner, M. Widera, S. Ciesek, F. Weber
This study shows that the Omicron variant of SARS-CoV-2 is more resistant to type I interferon responses compared to Delta and wildtype strains.
bioRxiv · Jan 20, 2022Microbiology